Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543593 | NSE Symbol : DBOL | ISIN : INE0I3401014 | Industry : Sugar |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
28-Apr-2025	02-May-2025	AGM	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 ,inter alia, to consider and approve 1. To consider and approve the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31, 2025. 2. To recommend dividend, if any, on equity shares of the Company for the financial year 2024-25. 3. To fix date of 5th Annual General Meeting. A.G.M. & Audited Results & Final Dividend The Board of Directors at its meeting held today i.e. Friday, May 02, 2025 recommends the final dividend of Rs. 1.25 per equity shares. (As Per BSE Announcement Dated on 02.05.2025)
27-Mar-2025	02-Apr-2025	Employee Stock Option	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/04/2025 inter alia to consider and approve the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations 2021. outcome of Board Meeting held on April 02, 2025 (As Per Bse Announcement Dated on 02.04.2025)
30-Jan-2025	04-Feb-2025	Quarterly Results	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve 1. the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024. 2. the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations 2021. Outcome of the Board Meeting held on Tuesday, February 04, 2025 interalia approving standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that the Board at its meeting held on Tuesday, February 04, 2025 approved the re-appointment of non-executive Independent Directors of the Company. (As Per BSE Announcement dated on 04.02.2025)
28-Oct-2024	04-Nov-2024	Quarterly Results	Quarterly Results Pursuant to the provisions of the Regulations 33 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (herein after referred to as 'Listing Regulation'), we wish to inform you that, the Board of Directors at its Meeting held today i.e. Monday, November 4, 2024, has inter-alia approved the following (As per BSE Announcement Dated on 04/11/2024)
19-Jul-2024	25-Jul-2024	Quarterly Results	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024. Pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015, we wish to intimate that the Board at its meeting held on July 25, 2024 has approved the financial results for the quarter ended June 30, 2024. Unaudited Financial Results for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 25/07/2024)
18-Apr-2024	24-Apr-2024	Accounts	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve 1. The audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2024. 2. To recommend dividend if any on equity shares of the Company for the financial year 2023-24. 3. To fix date of 4th Annual General Meeting. The Board of Directors at its Meeting held today i.e. Wednesday, April 24, 2024, has inter-alia approved the following: i) Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2024. ii) Recommendation of payment of dividend of Rs. 2.50 per equity share of Rs. 10 each for the financial year ended on March 31, 2024 subject to approval of shareholders at the ensuing 4th Annual General Meeting. The record date for the purpose of payment of Dividend for the financial year ended on March 31, 2024 shall be June 28, 2024. iii) Proposal to convene and hold the 4th Annual General Meeting of the Shareholders of the Company on July 5, 2024. iv) Re-appointment of Mr. Sandeep Kumar (DIN: 06906510) as Whole Time Director for a period of 1 year w.e.f. May 05, 2024, subject to approval of shareholders of the Company at the ensuing AGM of the Company Audited Financial results for the quarter and year ended March 31, 2024 The Board at its meeting held on April 24, 2024 recommended the payment of dividend at the rate of Rs. 2.50 per equity shares, to the shareholders of the Company at the ensuing Annual General Meeting of the Company (As Per BSE Announcement dated on 24.04.2024)
05-Feb-2024	05-Feb-2024	Others	Pursuant to the provisions of the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (herein after referred to as 'Listing Regulation'), we wish to inform you that, the Board of Directors at its Meeting held today i.e. Monday, February 05, 2024, has approved the conversion of 100 KL per day plant of existing molasses based distillery at Unit Asmoli into dual feed distillery i.e. molasses and grain based distillery with proposed capex of Rs. 50 crores. The project is expected to be operational by October 2024.
12-Jan-2024	18-Jan-2024	Quarterly Results	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023. Pursuant to the Regulation 33 of SEBI (LODR) Regulation, 2015, we submit unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023 along with Limited Review Report of Statutory Auditors. (As Per BSE Announcement dated on 18.01.2024)
03-Oct-2023	09-Oct-2023	Quarterly Results	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2023 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2023. The Board of Directors at its Meeting held today i.e. Monday, October 09, 2023, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2023. ii) Considering the present sugar scenario, the Board has decided to keep on hold the installation of Greenfield distillery at Unit Meerganj till further decision. The project was expected to be operational by July 2025, as approved in last Board meeting held on July 25, 2023. The Board at its meeting held on October 09, 2023 approved the unaudited financial results for the quarter and half year ended September 30, 2023. (As Per BSE Announcement dated on 09.10.2023)
19-Jul-2023	25-Jul-2023	Accounts	DHAMPUR BIO ORGANICS LIMITED has informed BSE about Board Meeting to be held on 25 Jul 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2023 ,inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023. Pursuant to the provisions of the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (herein after referred to as 'Listing Regulation'), we wish to inform you that, the Board of Directors at its Meeting held today i.e. Tuesday, July 25, 2023, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2023. ii) Appointment of Internal Auditors for the year ending March 31, 2024. iii) Expansion in crushing capacity of Division Sugar at Unit Asmoli, Uttar Pradesh of the Company by 3,500 Tonnes Crushing per day (TCD) i.e. from 9,000 TCD to 12,500 TCD. With the proposed expansion, the total capacity of the Company will stand augmented from 26,000 TCD to 29,500 TCD. iv) Installation of Greenfield Distillery at Unit Meerganj having capacity of 200,000 LPD (expandable upto 300,000 LPD) (As per BSE Announcement Dated on 25/07/2023)
19-Apr-2023	25-Apr-2023	Accounts	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Regulations) Notice is hereby given that meeting of Board of Directors of the Company is scheduled to be held on Tuesday April 25 2023 to consider the following: 1. To consider and approve the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2023 2. To recommend dividend if any on equity shares of the Company for the financial year 2022-23. 3. To fix date of 3rd Annual General Meeting. The Board of Directors of Dhampur Bio Organics Limited at its Meeting held today i.e. April 25, 2023, has inter-alia approved the following: i) Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2023. ii) Recommendation of payment of dividend of Rs. 3.50 per equity share of Rs. 10 each for the financial year ended on March 31, 2023 subject to approval of shareholders at the ensuing 3rd Annual General Meeting. iii) Proposal to convene and hold the 3rd Annual General Meeting of the Shareholders of the Company on June 30, 2023. iv) Expansion of Sugar Units Capacity by 4000 Tonnes Crushing per day (TCD) each at Unit Meerganj, Uttar Pradesh from 5,000 TCD to 9000 TCD of the Company. With the proposed expansion, the total capacity of the Company will stand augmented from 22000 TCD to 26000 TCD. Recommendation of payment of dividend of Rs. 3.50 per equity share of Rs. 10 each for the financial year ended on March 31, 2023 subject to approval of shareholders at the ensuing 3rd Annual General Meeting. With reference to the outcome of the Board Meeting submitted by the Company today i.e. April 25, 2023 (also submitted in quick results, xbrl utility, dividend and record date), we wish to inform you that the conclusion time of Board Meeting held on April 25, 2023 was inadvertently mentioned as 08:15 P.M. instead of 09:15 P.M. (As Per BSE Announcement dated on 25.04.2023) Audited Financial results (Standalone and Consolidated) along with declaration of unmodified opinion for the financial year ended March 31, 2023. (As Per BSE Announcement Dated on 29/04/2023)
17-Jan-2023	23-Jan-2023	Quarterly Results	Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2023 ,inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2022. Pursuant to the provisions of the SEBI Listing Regulations, we wish to inform you that, the Board of Directors at its Meeting held today i.e. January 23, 2023, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2022. We are enclosing herewith: a) The Unaudited (Standalone & Consolidated) Financial Results of the Company for quarter and nine months ended on December 31, 2022; b) Limited Review Reports of the Statutory Auditors on the Standalone and Consolidated Financial Results of the Company for quarter and nine months ended on December 31, 2022; The same are also being uploaded on the website of the Company i.e. http://www.dhampur.com/investor/financials. The Unaudited Financial Results shall be published in newspapers as per the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 6:45 p.m. (IST) and concluded at 07:25 p.m. (IST). (As per BSE Announcement Dated on 23/01/2023) Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith the copies of Business Standard (English and Hindi both) dated January 24, 2023 wherein the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31, 2022 have been published. Pursuant to the provisions of the SEBI Listing Regulations, we wish to inform you that, the Board of Directors at its Meeting held today i.e. January 23, 2023, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2022. We are enclosing herewith: a) The Unaudited (Standalone & Consolidated) Financial Results of the Company for quarter and nine months ended on December 31, 2022; b) Limited Review Reports of the Statutory Auditors on the Standalone and Consolidated Financial Results of the Company for quarter and nine months ended on December 31, 2022 (As Per BSE Announcement Dated on 24/01/2023)
14-Oct-2022	21-Oct-2022	Quarterly Results	Quarterly Results Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022 ,inter alia, to consider and approve the un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2022. Dhampur Bio Organics Limited has informed the Exchange about Board Meeting held on 21-Oct-2022 to consider financial statements for the period ended September 2022 (As Per NSE Announcement Dated on 21.10.2022) Pursuant to the provisions of the SEBI Listing Regulations, we wish to inform you that, the Board of Directors at its Meeting held today i.e. October 21, 2022, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2022. We are enclosing herewith: a. The Unaudited (Standalone & Consolidated) Financial Results of the Company for quarter and half year ended on September 30, 2022; b. Limited Review Reports of the Statutory Auditors on the Standalone and Consolidated Financial Results of the Company for quarter and half year ended September 30, 2022; The same are also being uploaded on the website of the Company i.e. http://dbol.dhampur.com/investor/financials. The Unaudited Financial Results shall be published in newspapers as per the Listing Regulations. Pursuant to the provisions of the SEBI Listing Regulations, we wish to inform you that, the Board of Directors at its Meeting held today i.e. October 21, 2022, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2022. We are enclosing herewith: a. The Unaudited (Standalone & Consolidated) Financial Results of the Company for quarter and half year ended on September 30, 2022; b. Limited Review Reports of the Statutory Auditors on the Standalone and Consolidated Financial Results of the Company for quarter and half year ended September 30, 2022; The same are also being uploaded on the website of the Company i.e. http://dbol.dhampur.com/investor/financials. The Unaudited Financial Results shall be published in newspapers as per the Listing Regulations. (As per BSE Announcement Dated on 21/10/2022)

LOGIN HERE

Dhampur Bio Organics Ltd

Board Meeting